Literature DB >> 19664141

Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome.

P Szodoray1, G Papp, I F Horvath, S Barath, S Sipka, B Nakken, M Zeher.   

Abstract

The aim of the present study was to describe subsets of cells with regulatory properties in primary Sjögren's syndrome (pSS), and to correlate these cell populations with clinical symptoms. Among the 32 investigated patients, 23 had extraglandular manifestations (EGMs), while nine had only glandular symptoms. Twenty healthy individuals served as controls. The percentages of natural killer (NK), natural killer T cells (NK T), interleukin (IL)-10 producing T regulatory type 1 (Tr1) cells and CD4(+)CD25(+) regulatory T cells (T(reg)) cells were determined by flow cytometry and serum cytokine levels of IL-4, IL-6, IL-10, tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma were evaluated by enzyme-linked immunosorbent assay (ELISA). Functional tests were carried out to assess the suppressor properties of T(reg) cells in patients and controls. Peripheral NK, NK T and Tr1 cell percentages were elevated in pSS, while CD4(+)CD25(+) T(reg) cells showed reduced frequencies in patients compared to controls. In pSS, elevated percentages of NK T, Tr1 and CD4(+)CD25(+) T(reg) cells were observed in patients with EGMs, when compared to patients with sicca symptoms only. CD4(+)CD25(+) T(reg) cell percentages showed a negative correlation with sialometry values. The in vitro functional assay demonstrated lower suppression activity of CD4(+)CD25(+) T(reg) cells in patients compared to controls. Serum IL-6 and TNF-alpha levels were elevated, while IL-10 was decreased in patients compared to controls. Negative correlation was found between IL-10 levels and the percentages of Tr1 cells. Changes in the investigated subsets of regulatory cells in pSS may contribute to the development and progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664141      PMCID: PMC2745027          DOI: 10.1111/j.1365-2249.2009.03966.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

3.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.

Authors:  S Barath; M Aleksza; T Tarr; S Sipka; G Szegedi; E Kiss
Journal:  Lupus       Date:  2007       Impact factor: 2.911

5.  Regulatory NK cells suppress antigen-specific T cell responses.

Authors:  Gunnur Deniz; Gaye Erten; Umut Can Kücüksezer; Dilara Kocacik; Christian Karagiannidis; Esin Aktas; Cezmi A Akdis; Mubeccel Akdis
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

6.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

Authors:  Thomas Korn; Jayagopala Reddy; Wenda Gao; Estelle Bettelli; Amit Awasthi; Troels R Petersen; B Thomas Bäckström; Raymond A Sobel; Kai W Wucherpfennig; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Med       Date:  2007-03-25       Impact factor: 53.440

8.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

Authors:  Anna Balandina; Sandrine Lécart; Philippe Dartevelle; Abdelhadi Saoudi; Sonia Berrih-Aknin
Journal:  Blood       Date:  2004-09-28       Impact factor: 22.113

9.  Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis.

Authors:  Xiang Li; Bao-Guo Xiao; Jian-Ying Xi; Chuan-Zhen Lu; Jia-Hong Lu
Journal:  Clin Immunol       Date:  2007-11-28       Impact factor: 3.969

10.  T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.

Authors:  Xiaomei Li; Xiangpei Li; Long Qian; Guosheng Wang; Hong Zhang; Xiaoqiu Wang; Ke Chen; Zhimin Zhai; Qing Li; Yiping Wang; David C H Harris
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666

View more
  30 in total

1.  A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  K Szabó; G Papp; A Szántó; T Tarr; M Zeher
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

2.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

3.  When killers become helpers.

Authors:  Umesh S Deshmukh; Harini Bagavant
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

4.  NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.

Authors:  Sylvie Rusakiewicz; Gaetane Nocturne; Thierry Lazure; Michaela Semeraro; Caroline Flament; Sophie Caillat-Zucman; Damien Sène; Nicolas Delahaye; Eric Vivier; Kariman Chaba; Vichnou Poirier-Colame; Gunnel Nordmark; Maija-Leena Eloranta; Per Eriksson; Elke Theander; Helena Forsblad-d'Elia; Roald Omdal; Marie Wahren-Herlenius; Roland Jonsson; Lars Rönnblom; Joanne Nititham; Kimberly E Taylor; Christopher J Lessard; Kathy L Moser Sivils; Jacques-Eric Gottenberg; Lindsey A Criswell; Corinne Miceli-Richard; Laurence Zitvogel; Xavier Mariette
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

Review 5.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 6.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

Review 7.  Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.

Authors:  Kiley Bax; Paul J Isackson; Molly Moore; Julian L Ambrus
Journal:  Curr Rheumatol Rep       Date:  2020-02-14       Impact factor: 4.592

Review 8.  Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.

Authors:  Britt Nakken; Edit Bodolay; Peter Szodoray
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 9.  Dry eye disease: an immune-mediated ocular surface disorder.

Authors:  William Stevenson; Sunil K Chauhan; Reza Dana
Journal:  Arch Ophthalmol       Date:  2012-01

10.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.